| 5/1/2014 | CV | Market Commentary: Midday Commentary: Hologic adds outright after earnings; JDS Uniphase reports disappointing results
|
| 5/1/2014 | CV | Market Commentary: Convertibles muted amid earnings reports; Hologic, Merrimack add outright, flat on hedge
|
| 8/21/2013 | CV | JDSU greenshoe exercised, lifts 0.625% convertible sale to $650 million
|
| 8/19/2013 | CV | Market Commentary: Cobalt drops outright, comes in on hedge; B2Gold to price $225 million; Spansion on tap
|
| 8/16/2013 | CV | Market Commentary: New JDS Uniphase jumps after pricing on rich end; Merrimack extends slide; AMR wanes
|
| 8/16/2013 | CV | New Issue: JDS Uniphase sells $575 million 20-year convertibles at 0.625%, up 40%
|
| 8/15/2013 | CV | JDS Uniphase to price $575 million 20-year convertibles to yield 0.75%-1.25%, up 35%-40%
|
| 8/15/2013 | CV | Market Commentary: Planned JDS Uniphase deal in focus; Starwood trades lower; REITs weaker; Hertz active
|
| 5/15/2013 | CVLM | JDSU receives puts for $160.58 million of 1% convertible notes due 2026
|
| 1/11/2013 | CV | Market Commentary: Upsized Silver Standard sees quiet debut with bonds ending near par; ArcelorMittal flat
|
| 1/3/2013 | CV | Market Commentary: SunPower jumps on MidAmerican deal; Cobalt extends gains, adds on swap; JDS trades at par
|
| 11/15/2011 | CV | Soros Fund reports sizable stakes in convertibles in quarterly tally
|
| 5/4/2011 | CV | Market Commentary: Novellus up in the gray ahead of pricing; MGM gains on swap; Alaska Communications quiet
|
| 4/29/2009 | CV | JDS Uniphase buys back $20 million in convertibles, reduces overall debt by $50 million
|
| 8/27/2008 | CV | JDS Uniphase buys back $300 million zero-coupon convertibles in fiscal 2008
|
| 5/6/2008 | CV | JDS Uniphase buys back $75 million of its zero-coupon convertibles
|
| 2/6/2008 | CV | Market Commentary: AAR prices upsized deal cheap, trades lower; Disney, JDS Uniphase up on earnings; Micron down on sales worries
|
| 11/7/2007 | CV | JDS Uniphase buys back $167 million of zero-coupon convertibles
|
| 8/22/2007 | CV | Market Commentary: Countrywide continues recovery; Amgen, BioMarin nudge up; Ford edges down; market mayhem 'dying down'
|
| 1/19/2007 | CV | Market Commentary: Health Management firm despite soft stock; JDS Uniphase jumps on outlook; Covanta plans deal
|
| 12/1/2006 | CV | Market Commentary: JDS Uniphase firm on sector concerns; Goodrich quiet in debut; Amgen, Gilead hit on broad pullback
|
| 8/31/2006 | CV | Market Commentary: Valassis improves on attempt to end deal; JDSU falls with poor guidance; CompuCredit rides stock rally
|
| 6/5/2006 | CV | JDS greenshoe exercised, increasing convertibles to $425 million
|
| 5/12/2006 | CV | New Issue: JDS Uniphase prices $375 million of 20-year convertibles within talk at 1%, up 25%
|
| 5/12/2006 | CV | Market Commentary: Amkor, Manor Care gain on debuts; JDS Uniphase pulled down by stock; Global Crossing plans deal
|
| 5/11/2006 | CV | JDSU prices $375 million convertibles to yield 1%, up 25%
|
| 5/11/2006 | CV | Market Commentary: Amkor, JDS Uniphase, Manor Care gain in gray; Scottish Re improves on stock rebound; Merix prices deal
|
| 5/10/2006 | CV | JDS Uniphase to price $375 million of 20-year convertibles, talked at 0.5%-1%, up 20%-25%
|
| 5/10/2006 | CV | Market Commentary: SanDisk, Broadwing climb on debuts; Amkor, JDS Uniphase, Manor Care plan deals; Teva steady on loss
|
| 5/4/2006 | CV | Market Commentary: Bausch and Lomb up dollar-neutral on debt tenders; JDS Uniphase falls outright on poor guidance
|
| 4/18/2006 | CV | Market Commentary: Freeport-McMoran surges on strong earnings; JDS Uniphase rebounds; Gilead plans $1.1 billion deal
|
| 4/17/2006 | CV | Market Commentary: Delta, JetBlue dive on oil, downgrades; Red Hat falls, Novell gains on Oracle CEO's comments
|
| 3/8/2006 | CV | Market Commentary: Informatica's surprise issue, Coherent up on debuts; Albany International's new deal struggles
|
| 2/1/2006 | CV | Market Commentary: JetBlue, Pixelworks down on earnings, but Cymer up; Schlumberger drops
|
| 8/12/2005 | CV | Market Commentary: JDS Uniphase, Human Genome weaken in thinly traded convertibles market
|
| 5/24/2005 | CV | Market Commentary: CompuCredit prices wide, gets reoffered at 97, still craters; JDS Uniphase joins tech party;
|
| 5/23/2005 | CV | Market Commentary: America West intrigues traders; CompuCredit pitches overnighter; JDS Uniphase off; REITs mixed
|
| 1/13/2005 | CV | Market Commentary: Fannie seesaws up, closes lower; UnumProvident mandatory slides; Conexant 4% due 2007 drops
|
| 9/21/2004 | CV | Market Commentary: CenterPoint convertibles dip on lower cost recovery ruling; Calpine issues continue slide
|
| 3/30/2004 | CV | New Issue: ABN Amro sells $4 million 14.5% reverse exchangeables linked to JDS Uniphase
|
| 1/20/2004 | CV | Market Commentary: Deals for $1.43 billion emerge; El Paso lifts power group; merger buzz stirs players
|
| 1/16/2004 | CV | Market Commentary: Juniper zooms 30-plus points on positive earnings; several techs, telecoms join the party
|
| 1/7/2004 | CV | Market Commentary: Coeur d'Alene bid up 1 point in gray market; Red Hat hits 103.25 bid; Duke rebounds
|
| 10/31/2003 | CV | JDS Uniphase greenshoe exercised, raising convertibles to $475 million
|
| 10/31/2003 | CV | Market Commentary: New Elan issue is a treat, zooming past 110 in heavy U.S. trading activity
|
| 10/30/2003 | CV | Market Commentary: Northwest reoffered at 98, edges up slightly; Elan is a blowout at 6.5%, up 49.9%
|
| 10/29/2003 | CV | Market Commentary: Gilead plunges 11-30 points on earnings disappointment; Northwest, Elan deals pops up;
|
| 10/28/2003 | CV | New Issue: JDS Uniphase sells $400 million convertible to yield 0%, up 38%
|
| 10/28/2003 | CV | Market Commentary: United Rentals, JDS Uniphase both repriced at 98; United Rentals drops to 95, JDS edges higher
|
| 10/27/2003 | CV | JDS Uniphase $400 million overnight convertible seen at 0% yield, up 37.6%
|
| 10/27/2003 | CV | Market Commentary: Deals emerge for $860 million; Juniper spikes 4.5 points on call; Anthem falls on WellPoint merger
|
| 1/30/2002 | CV | New Issue: Merrill prices $55.275 million 9% callable STRIDES exchangeable for JDS
|
